Signal active
Bio
Vikas Sinha is the co-founder and chief financial officer of ElevateBio.
He used to be the Executive Vice President and Chief Financial Officer for Alexion. In this role, Mr. Sinha has responsibility for global financial management, corporate & strategic development, investor relations, information technology, engineering, and real estate & security activities.
Previously, Mr. Sinha spent 11 years with Bayer AG, where he held numerous positions in the United States, Japan, Germany and Canada, including, most recently, the position of Vice President and Chief Financial Officer of Bayer Pharmaceutical Corporation, USA. During his time with Bayer, Mr. Sinha held responsibility for a variety of business functions, including financial and business risk management, strategic planning, contracting, customer services, information systems, and supply chain and site administration in North America. He also served as Vice President and Chief Financial Officer of Bayer Yakuhin Ltd., in Japan, Manager of Mergers and Acquisitions with Bayer AG in Germany, and began his career at Bayer in Toronto in a healthcare executive development program. Prior to Bayer, Mr. Sinha also held several positions of increasing responsibilities with ANZ Bank and Citibank in South Asia.
Mr. Sinha holds a master's degree in business administration from the Asian Institute of Management. He is also a qualified Chartered Accountant from the Institute of Chartered Accountants of India.
Location
Boston, Massachusetts, United States, North America
Social
Primary Organization
2017
2
0
1
251-500
Information Technology, Biotechnology, Alternative Medicine
Jobs history
3
Basecamp Bio
Founder & Chief Financial Officer
2017 - Current
President & CFO
2018 - Current
ElevateBio
Chief Financial Officer
2017 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Vikas Sinha is the Chief Financial Officer at ElevateBio, based in United States, North America. With a background in Information Technology, Vikas Sinha has a rich history of leadership and innovation. Vikas Sinha studied MBA Business Administration @ Asian Institute of Management. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
1
1
Personal investment
1
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Jul 17, 2020 | Verona Pharma | Post-IPO Equity - Verona Pharma | 200.0M |
Partner investment
0
There is no partner investment available on this profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.